Luigi Mangione’s Upcoming Federal Court Appearance
Luigi Mangione is scheduled to appear at Manhattan federal court on Monday morning in connection with the murder of UnitedHealthcare executive Brian Thompson.
Mangione is accused of killing Thompson on 4 December 2024 on a City street. He faces murder and weapons charges in his state-level case, while the federal proceedings include stalking charges.
Case Background and Public Reaction
The death of Brian Thompson triggered an extensive manhunt for his alleged killer and reignited public scrutiny of the US for-profit healthcare industry. Mangione has also attracted a small but vocal group of supporters known as Mangionistas.
Mangione has pleaded not guilty to charges in both the state and federal cases.
State Case Developments and Psychiatric Defense
Mangione’s scheduled federal court appearance follows recent developments in his state case, which has entered a phase of uncertainty. On 17 June, Judge Gregory Carro, who is presiding over the state-level case, disclosed that Mangione’s defense lawyers intended to pursue a psychiatric defense.
Judge Carro stated that Mangione’s legal team planned to invoke an “extreme emotional disturbance at the time of the occurrence” as part of their defense strategy. He also ordered the defense to inform prosecutors about the specific “mental defect” Mangione allegedly experienced during the shooting.
Additionally, Judge Carro announced his decision to “unseal the record” from a 3 June conference that had been held behind closed doors, despite requests from reporters for the proceeding to be open. Court proceedings in New York state and the US are generally presumed to be public, with rare exceptions. Members of the press and public have the right to petition for access, but Carro did not entertain arguments for access before this proceeding.
Details of the Psychiatric Defense Notice
The unsealed record concerns a 250.10 notice, which Judge Carro explained as a defense team declaration that “he was proceeding with an affirmative psychiatric defense … extreme emotional disturbance [EED] at the time and place of the occurrence.”
The transcript of the unsealed conference, released on 18 June, provided insight into why lead defense attorney Karen Friedman Agnifilo might have preferred to keep the proceeding confidential.
“As you know, your honor, if a defendant goes with an EED defense, they’re essentially admitting publicly that they committed this crime,” she said.
Shortly after the transcript was unsealed, Mangione’s defense submitted a letter indicating their intention to withdraw the 250.10 notice. Judge Carro then stated that due to the withdrawal of the 250.10 notice, his previous order sealing the record would remain in effect.
Implications of the Withdrawal and Possible Defense Strategies
Although it was widely reported that withdrawing the 250.10 notice meant Mangione would not pursue a psychiatric defense, a legal expert with experience in extreme emotional disturbance defenses noted that Mangione could still pursue such a defense.
A 250.10 notice requires the defense to share psychiatric information with prosecutors, including expert assessments. However, Mangione’s defense could still attempt to demonstrate mental distress by other means, such as having Mangione testify or using evidence presented by prosecutors to establish severe mental illness. This approach could aim to secure a manslaughter verdict instead of a murder conviction.
